Health care stocks were higher Thursday afternoon, with the NYSE Health Care Index rising 0.6% and the Health Care Select Sector SPDR Fund (XLV) adding 0.9%.
The iShares Biotechnology ETF (IBB) rose 1.3%.
In corporate news, Telomir Pharmaceuticals (TELO) said Thursday that a preclinical study showed "significant" age reversal effects in subjects treated with Telomir-1, a compound designed to reverse aging and support longevity. Its shares popped 4.3%.
HOOKIPA Pharma (HOOK) shares tumbled 8% after the company said late Wednesday that it would reduce its workforce by about 80% as part of a restructuring plan.
Biomerica (BMRA) said Thursday it received three international patents covering the technology and methods for treating gastroesophageal reflux disease, Crohn's disease, and ulcerative colitis using its inFoods technology. Its shares added 1.6%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。